Start |  Archive |  Services |  About Us |  Contact

Search News

FDA Approvals: Rituxan and Emsam

The FDA has approved a new indication for rituximab (Rituxan) and selegiline transdermal system (Emsam). (CME,CE)Yael Waknine,Gary Vogin

Continue to FDA Approvals: Rituxan and Emsam on Medscape Medical News Headlines.

Your health is news!

Medical buzz is a member of the HarWester Network.